The program was originally established in the 1980s after numerous lawsuits filed
against vaccine companies ran the risk of causing a vaccine shortage and reducing overall vaccination rates in the United States.
Not exact matches
PaxVax is a fully integrated specialty
vaccine company committed to developing and commercializing innovative
vaccines against infectious diseases.
Horse owners have launched a $ 53 million lawsuit
against the pharmaceutical
company responsible for developing the Hendra virus
vaccine.
Democrats and liberal groups have successfully attacked Heck on social security privatization and a vote in the state Senate
against a bill that would have required insurance
companies to cover a
vaccine for cervical cancer.
The
company has begun human testing of its mRNA drugs for cardiovascular disease and cancer, and for
vaccines against the flu, Zika, and chikungunya viruses.
The team claims its work, funded by Tonix, a pharmaceutical
company headquartered in New York City, could lead to a safer, more effective
vaccine against smallpox.
The method is relatively new, but far bacteria - based
vaccines have proven effective: A seasonal flu
vaccine produced by VaxInnate successfully protected humans in clinical trials, and the
company's recently tested swine flu
vaccine immunized mice
against the virus.
The
vaccine was most effective
against H3N2, increasing antibody titers (a measure how much antibody is produced after vaccination) fourfold in more than 81 percent of who received it, according to the
company.
Already scientists at Human Genome Sciences in Rockville, Maryland — a biotech
company affiliated with Venter's research institute — have begun working on a more effective
vaccine against Haemophilus.
In order to promote their patented drugs and
vaccines against flu, pharmaceutical
companies have influenced scientists and official agencies, responsible for public health standards, to alarm governments worldwide.
The
company is developing immunotherapies for cancer and prophylactic
vaccines against infectious diseases, both based on RNA molecules.
When injected into animals, Bachmann's virus - bacteria hybrid induces a strong antibody response that his
company, Cytos Biotechnology, is exploiting to design
vaccines against two common inflammatory disorders.
The
company is now developing
vaccines against ragweed, house dust mites, Japanese cedar and pollen.
If GSK alone must do the filling, this will affect the
company's ability to produce other
vaccines already on the market, including ones that protect
against rotavirus, measles, mumps, and rubella, the document said.
Baltimore biotechnology
company Profectus BioSciences is testing a
vaccine to guard
against the Ebola virus on 39 human subjects, a first step toward administering it more broadly to people at risk of exposure to the deadly pathogen.
CAMBRIDGE, Mass., April 27, 2017 — Moderna Therapeutics, a clinical stage biotechnology
company that is pioneering messenger RNA (mRNA) Therapeutics ™ to create a new generation of transformative medicines for patients, today announced positive interim data from an ongoing Phase 1 study of mRNA - 1440, an mRNA infectious disease
vaccine against avian H10N8 influenza, demonstrating mRNA - 1440 induced high levels of immunogenicity, and was safe and well tolerated.
There her research focused on inventing molecular, bead and array - based approaches to enable novel
vaccine discovery
against infectious and chronic diseases At the University of Texas Southwestern Medical she pursued technologies that became the basis of a Texas biotechnology
company that was ultimately acquired by MacroGenics, Inc..
Sinovac Biotech, Ltd. is a fully integrated, profitable China - based biopharmaceutical
company that focuses on the research, development, manufacturing and commercialization of
vaccines that protect
against human infectious diseases.
Sinovac Biotech Ltd. is biopharmaceutical
company that focuses on research, development, manufacturing and commercialization of
vaccines that protect
against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza and mumps, as well as animal rabies
vaccine.
In dogs it has been demonstrated that when intranasal Bordetella bronchiseptica
vaccines are used for initial vaccination and injectable
vaccines are used for subsequent doses, immune responses may be improved.3, 4 Similar techniques combining oral and injectable
vaccines have been demonstrated to provide a more robust immune response in humans.5 Zoetis is excited to be the only
company to offer veterinarians the capability to use this concept for vaccination of their canine patients
against B.bronchiseptica.
Zoetis Inc. has started shipping Vanguard CIV H3N2 / H3N8, the
company's newest
vaccine against canine influenza virus.
Whereas Seidel's connection to
vaccine companies had little bearing on the lawsuit
against them, here, the identity of commenters could potentially yield material relevant to Albritton's case, such as the source of any defamatory material or the scope of the injury to reputation.